MGP Database

New search | Record Overview | Ontology/Pathway Information | Domain Information | UniProt Annotations | Related Proteins
MGP001497

UniProt Annotations

Entry Information
Gene NameHarvey rat sarcoma viral oncogene homolog
Protein EntryRASH_HUMAN
UniProt IDP01112
SpeciesHuman
Comments
Comment typeDescription
Alternative ProductsEvent=Alternative splicing; Named isoforms=2; Name=1; Synonyms=H-Ras4A, p21; IsoId=P01112-1; Sequence=Displayed; Name=2; Synonyms=H-RasIDX, p19; IsoId=P01112-2; Sequence=VSP_041597;
DiseaseBladder cancer (BLC) [MIM:109800]: A malignancy originating in tissues of the urinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladder cancers are transitional cell carcinomas that begin in cells that normally make up the inner lining of the bladder. Other types of bladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmental influences. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.
DiseaseCongenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040]: Variant of Costello syndrome. {ECO:0000269|PubMed:17412879}. Note=The disease is caused by mutations affecting the gene represented in this entry.
DiseaseCostello syndrome (CSTLO) [MIM:218040]: A rare condition characterized by prenatally increased growth, postnatal growth deficiency, mental retardation, distinctive facial appearance, cardiovascular abnormalities (typically pulmonic stenosis, hypertrophic cardiomyopathy and/or atrial tachycardia), tumor predisposition, skin and musculoskeletal abnormalities. {ECO:0000269|PubMed:16170316, ECO:0000269|PubMed:16329078, ECO:0000269|PubMed:16443854, ECO:0000269|PubMed:17054105, ECO:0000269|PubMed:18039947, ECO:0000269|PubMed:18247425, ECO:0000269|PubMed:19995790}. Note=The disease is caused by mutations affecting the gene represented in this entry.
DiseaseHurthle cell thyroid carcinoma (HCTC) [MIM:607464]: A rare type of thyroid cancer accounting for only about 3-10% of all differentiated thyroid cancers. These neoplasms are considered a variant of follicular carcinoma of the thyroid and are referred to as follicular carcinoma, oxyphilic type. {ECO:0000269|PubMed:12727991}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.
DiseaseNote=Mutations which change positions 12, 13 or 61 activate the potential of HRAS to transform cultured cells and are implicated in a variety of human tumors.
DiseaseSchimmelpenning-Feuerstein-Mims syndrome (SFM) [MIM:163200]: A disease characterized by sebaceous nevi, often on the face, associated with variable ipsilateral abnormalities of the central nervous system, ocular anomalies, and skeletal defects. Many oral manifestations have been reported, not only including hypoplastic and malformed teeth, and mucosal papillomatosis, but also ankyloglossia, hemihyperplastic tongue, intraoral nevus, giant cell granuloma, ameloblastoma, bone cysts, follicular cysts, oligodontia, and odontodysplasia. Sebaceous nevi follow the lines of Blaschko and these can continue as linear intraoral lesions, as in mucosal papillomatosis. {ECO:0000269|PubMed:22683711}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Enzyme RegulationAlternates between an inactive form bound to GDP and an active form bound to GTP. Activated by a guanine nucleotide-exchange factor (GEF) and inactivated by a GTPase- activating protein (GAP).
FunctionRas proteins bind GDP/GTP and possess intrinsic GTPase activity. {ECO:0000269|PubMed:12740440, ECO:0000269|PubMed:14500341, ECO:0000269|PubMed:9020151}.
InteractionQ7Z569:BRAP; NbExp=3; IntAct=EBI-350145, EBI-349900; P42337:Pik3ca (xeno); NbExp=2; IntAct=EBI-350145, EBI-641748; O00329:PIK3CD; NbExp=2; IntAct=EBI-350145, EBI-718309; O00329-2:PIK3CD; NbExp=2; IntAct=EBI-350145, EBI-6470902; Q9Z0S9:Rabac1 (xeno); NbExp=4; IntAct=EBI-350145, EBI-476965; P04049:RAF1; NbExp=14; IntAct=EBI-350145, EBI-365996; Q12967:RALGDS; NbExp=2; IntAct=EBI-350145, EBI-365861; Q9EQZ6:Rapgef4 (xeno); NbExp=3; IntAct=EBI-350145, EBI-772212; Q9NS23-2:RASSF1; NbExp=2; IntAct=EBI-350145, EBI-438698; Q8WWW0:RASSF5; NbExp=2; IntAct=EBI-350145, EBI-367390; Q5EBH1:Rassf5 (xeno); NbExp=11; IntAct=EBI-350145, EBI-960530; Q5EBH1-2:Rassf5 (xeno); NbExp=3; IntAct=EBI-350145, EBI-960547; Q13671:RIN1; NbExp=5; IntAct=EBI-350145, EBI-366017; Q07889:SOS1; NbExp=8; IntAct=EBI-350145, EBI-297487;
Mass SpectrometryMass=6223; Mass_error=2; Method=Electrospray; Range=112-166; Evidence={ECO:0000269|PubMed:9020151};
Mass SpectrometryMass=6253; Mass_error=2; Method=Electrospray; Range=112-166; Note=Includes one nitric oxide molecule.; Evidence={ECO:0000269|PubMed:9020151};
PtmAcetylation at Lys-104 prevents interaction with guanine nucleotide exchange factors (GEFs). {ECO:0000250}.
PtmPalmitoylated by the ZDHHC9-GOLGA7 complex. A continuous cycle of de- and re-palmitoylation regulates rapid exchange between plasma membrane and Golgi.
PtmS-nitrosylated; critical for redox regulation. Important for stimulating guanine nucleotide exchange. No structural perturbation on nitrosylation.
PtmThe covalent modification of cysteine by 15-deoxy-Delta12,14- prostaglandin-J2 is autocatalytic and reversible. It may occur as an alternative to other cysteine modifications, such as S- nitrosylation and S-palmitoylation.
SimilarityBelongs to the small GTPase superfamily. Ras family. {ECO:0000305}.
Subcellular LocationCell membrane. Cell membrane; Lipid-anchor; Cytoplasmic side. Golgi apparatus. Golgi apparatus membrane; Lipid-anchor. Note=The active GTP-bound form is localized most strongly to membranes than the inactive GDP-bound form (By similarity). Shuttles between the plasma membrane and the Golgi apparatus. {ECO:0000250}.
Subcellular LocationIsoform 2: Nucleus. Cytoplasm. Cytoplasm, perinuclear region. Note=Colocalizes with GNB2L1 to the perinuclear region.
SubunitIn its GTP-bound form interacts with PLCE1. Interacts with TBC1D10C. Interacts with RGL3. Interacts with HSPD1. Found in a complex with at least BRAF, HRAS, MAP2K1, MAPK3 and RGS14. Interacts (active GTP-bound form) with RGS14 (via RBD 1 domain) (By similarity). Forms a signaling complex with RASGRP1 and DGKZ. Interacts with RASSF5. Interacts with PDE6D. Interacts with IKZF3. Interacts with GNB2L1. Interacts with PIK3CG; the interaction is required for membrane recruitment and beta-gamma G protein dimer- dependent activation of the PI3K gamma complex PIK3CG:PIK3R6 (By similarity). Interacts with RAPGEF2. {ECO:0000250, ECO:0000269|PubMed:10369681, ECO:0000269|PubMed:10608844, ECO:0000269|PubMed:11022048, ECO:0000269|PubMed:11257115, ECO:0000269|PubMed:11598133, ECO:0000269|PubMed:11980706, ECO:0000269|PubMed:14500341, ECO:0000269|PubMed:17230191, ECO:0000269|PubMed:18596699, ECO:0000269|PubMed:9219684}.
Tissue SpecificityWidely expressed. {ECO:0000269|PubMed:14500341}.
Web ResourceName=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/HRASID108.html";
  logo